Louisiana State University

LSU Digital Commons
Faculty Publications

School of Animal Sciences

8-15-2001

An α-helical
-helical domain within the carboxyl terminus of herpes
simplex virus type 1 (HSV-1) glycoprotein B (gB) is associated
with cell fusion and resistance to heparin inhibition of cell fusion
Timothy P. Foster
School of Veterinary Medicine

Jeff M. Melancon
School of Veterinary Medicine

Konstantin G. Kousoulas
School of Veterinary Medicine

Follow this and additional works at: https://digitalcommons.lsu.edu/animalsciences_pubs

Recommended Citation
Foster, T., Melancon, J., & Kousoulas, K. (2001). An α-helical domain within the carboxyl terminus of
herpes simplex virus type 1 (HSV-1) glycoprotein B (gB) is associated with cell fusion and resistance to
heparin inhibition of cell fusion. Virology, 287 (1), 18-29. https://doi.org/10.1006/viro.2001.1004

This Article is brought to you for free and open access by the School of Animal Sciences at LSU Digital Commons.
It has been accepted for inclusion in Faculty Publications by an authorized administrator of LSU Digital Commons.
For more information, please contact ir@lsu.edu.

Virology 287, 18–29 (2001)
doi:10.1006/viro.2001.1004, available online at http://www.idealibrary.com on

An ␣-Helical Domain within the Carboxyl Terminus of Herpes Simplex Virus Type 1 (HSV-1)
glycoprotein B (gB) is Associated with Cell Fusion and Resistance
to Heparin Inhibition of Cell Fusion
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Previous studies from our laboratory indicated that a 28-amino-acid carboxyl-terminal truncation of gB caused extensive
virus-induced cell fusion (Baghian et al., 1993, J Virol 67, 2396–2401). We tested the ability of additional truncations and
mutations within gB to cause cell fusion in the recently established virus-free cell fusion assay (Turner et al., 1998, J. Virol.
72, 873–875). Deletion of the carboxyl-terminal 28 amino acids of gB (gB⌬28), which removed part of the predicted ␣-helical
structure H17b, caused extensive cell fusion. A gB truncation specified by gB⌬36, which removed the entire H17b domain,
caused as much cell fusion as the gB⌬28 truncation. Similarly, gB(A874P) containing a substitution of an Ala with Pro within
H17b caused cell fusion. Heparin, a gB-specific inhibitor of virus-induced cell fusion, inhibited both wild-type gB and
gB(syn3)-mediated cell fusion. In contrast, fusion of cells transfected with gB(⌬28), gB(⌬36), or gB(A874P) was resistant to
heparin inhibition of cell fusion. We concluded the following: (1) The predicted ␣-helical structure of H17b within the carboxyl
terminus of gB is involved in both virus-induced and virus-free cell fusion. (2) Heparin is a specific inhibitor of gB-mediated
fusion in both systems. (3) Resistance to heparin inhibition of gB-mediated cell fusion is associated with the predicted
␣-helical structure H17b within the carboxyl terminus of gB. © 2001 Academic Press

UL25 (Addison et al., 1984; Cai et al., 1988; Forrester et
al., 1992; Ligas and Johnson, 1988; Roop et al., 1993).
Penetration of virus requires the interaction of gD with
specific cell surface receptors (Cocchi et al., 1998; Geraghty et al., 1998; Montgomery et al., 1996; Warner et al.,
1998).
Spread of infectious virus occurs either by release of
virions to extracellular spaces or through virus-induced
cell-to-cell fusion. Mutations, which cause extensive virus induced cell-to-cell fusion, can arise in at least four
genes of the HSV genome: the UL53-gK gene, the gB
gene, the UL20 gene, and the UL24 gene (Baines et al.,
1991; Bond and Person, 1984; Bzik et al., 1984b; Cai et al.,
1988; Debroy et al., 1985; DeLuca et al., 1982; Dolter et
al., 1994; Engel et al., 1993; Gage et al., 1993; Hutchinson
et al., 1992; Jacobson et al., 1989; Pogue-Geile and Spear,
1987; Ruyechan et al., 1979; Sanders et al., 1982; Weise et
al., 1987). However, like virus-to-cell fusion, gB, gD, gH,
and gL have been shown to be necessary and sufficient
to cause virus-induced cell fusion. The evidence is twofold. First, mutant viruses that do not express any one of
these four glycoproteins fail to produce syncytia (Cai et
al., 1988; Davis-Poynter et al., 1994; Ligas and Johnson,
1988; Roop et al., 1993). Similarly, transient expression of
HSV-1 or HSV-2 gB, gD, gH, and gL causes polykaryocyte
formation in transfected Cos cells (Muggeridge, 2000;
Turner et al., 1998). Glycoproteins gE (US8), gI (US7), and
gM (UL10), as well as the UL45 protein, may be able to
enhance virus-induced cell fusion, since deletions of
these genes cause inhibition of cell fusion (Davis-Poyn-

INTRODUCTION
Viral glycoproteins are key determinants in membrane
fusion events throughout the virus life cycle. Herpes
simplex viruses specify at least twelve glycoproteins: gB,
gC, gD, gE, gG, gH, gI, gJ, gK, gL gM, and gN, which are
expressed in infected cells. These glycoproteins function
in several important roles, including pH-independent virus entry via fusion of the viral envelope with cellular
membranes, cell-to-cell spread, virus-induced cell fusion, and egress of infectious virion particles (reviewed
in Mettenleiter, 2000; Spear, 1993). Recombinant mutant
viruses that lack gB (UL27), gD (US6), gH (UL22), or gL
(UL1) attach to cell surfaces through cell-surface glycosaminoglycans, but fail to penetrate, indicating these glycoproteins are required at least in part for virus-to-cell
fusion (Cai et al., 1988; Forrester et al., 1992; Ligas and
Johnson, 1988; Roop et al., 1993). Either of two HSV-1
glycoproteins, gC (UL44) or gB, can mediate binding of
virus to heparan sulfate proteoglycans on cellular surfaces. Accordingly, attachment is inhibited by soluble
heparin, a glycosaminoglycan closely related to heparan
sulfate (Gruenheid et al., 1993; Herold et al., 1991, 1994;
Shieh et al., 1992; WuDunn and Spear, 1989). Fusion
between the viral envelope and cell membrane requires
gB, gD, and gH/gL, and possibly the tegument protein
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ter et al., 1994; Haanes et al., 1994; Visalli and Brandt,
1991). Similarly, gC may be able to inhibit virus-induced
cell fusion of at least some cell types, which may explain
the lack of gC expression in many syncytial mutants
(Manservigi et al., 1977; Novotny et al., 1996; Pertel and
Spear, 1996). It is apparent there are similarities as well
as significant differences between the virus-induced cell
fusion and fusion of cells by transient co-expression of
gB, gD, and gH/gL. Both systems require the expression
of gD receptors for fusion to occur (Pertel et al., 2001;
Terry-Allison et al., 1998); however, the transient expression system, in contrast to the virus-induced cell fusion,
does not require the presence of heparan sulfate (Pertel
et al., 2001; Shieh and Spear, 1994). Additionally, viral
proteins that exhibit the ability to influence virus-induced
cell fusion do not produce similar effects in the transient
fusion assay system (Klupp et al., 2000; Turner et al.,
1998).
Glycoprotein B is highly conserved across all subfamilies of herpesviruses. It exists within cells as a homodimeric type I integral membrane protein that is Nglycosylated at multiple sites within the polypeptide.
Each 904-amino-acid (aa) monomer includes a cleavable
signal sequence, an extracellular domain of 696 aa, a
69-aa triple-pass transmembrane region, and a 109-aa
carboxyl-terminal domain. Single amino acid substitutions within two regions of the intracellular cytoplasmic
domain of gB were shown to cause syncytium formation
and were designated Region I (aa positions 816 and 817)
and Region II (aa positions 853, 854, and 857) (Bzik et al.,
1984a; Cai et al., 1988; Gage et al., 1993; Walev et al.,
1994). Deletion of the carboxyl-terminal 41 amino acids of
gB did not adversely affect viral infectivity and replication; whereas, deletion of 28 amino acids caused extensive virus-induced cell fusion (Baghian et al., 1993; Huff
et al., 1988).
We extended our previous findings by examining the
role of specific carboxyl-terminal domains of gB in cell
fusion in the context of viral infection as well as in a
transfection-fusion system. We show that an ␣-helical
domain within the gB carboxyl terminus appears to regulate cell fusion. Moreover, we provide evidence that
heparin inhibition of gB-mediated cell fusion is also regulated by the carboxyl terminus of gB for both virusinduced cell fusion as well as fusion by co-expression of
gB, gD, and gH/gL. In this regard, gB-mediated fusion
functions similarly for both fusion systems.
RESULTS
The effect of gB truncations on virus-independent cell
fusion
Previously, we investigated the effect of several gB
truncations on virus-induced cell fusion. We found that a
recombinant virus expressing a 28-amino-acid truncated
gB resulted in extensive virus-induced cell fusion
(Baghian et al., 1993). A schematic of the predicted struc-
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ture of the carboxyl terminus of gB showing the location
of relevant truncations and mutations is shown in Fig. 1.
The 28-amino-acid deletion of gB disrupts the predicted
␣-helical structure H17b composed of 16 amino acids. To
assess whether these gB truncations caused similar
effects in a virus-independent cell fusion assay, we
transfected COS7 cells with plasmids constitutively expressing glycoproteins gD, gH, and gL in the presence of
different mutated gB (Fig. 2). The extent of cell fusion was
quantified by counting nuclei in 100 polykaryocytes per
assay by two independent observers (Fig. 3, Table 1). As
shown previously, transient expression of full-length,
wild-type gB, gD, gH, and gL genes under the human
cytomegalovirus immediate early promoter (CMV-IE)
caused limited polykaryocyte formation (Turner et al.,
1998) (Fig. 2A). Similar numbers of polykaryocytes were
formed when the CMV-IE driven gB gene was substituted
with plasmid p9–2080 expressing gB under the adenovirus major late promoter (Ad-MLP). (Fig. 2B). Transfection controls that did not include gB failed to cause any
cell fusion (data not shown). Similarly, inclusion of p9–
1537 in the transfection fusion assay failed to cause any
cell fusion (Fig. 2C). Plasmid p9–1537 specifies gB containing an internal, in-frame truncation spanning amino
acids 130–697. This deletion causes rapid degradation of
the gB product (Baghian et al., 1993).
All gB mutants, which modified H17b, used in these
experiments expressed high levels of gB and similar
amounts of gB were detected on cell surfaces by immunofluorescence against paraformaldehyde-fixed transfected cells (Baghian et al., 1993; data not shown). Transfection with p9–1511 caused more than twofold increase
in cell fusion in comparison to wild-type gB (Fig. 2F, Table
1). An identical truncation of 28 amino acids in gB specified by mutant virus amb1511 caused extensive cell
fusion (Baghian et al., 1993). Interestingly, transfection of
the 1511(gB⌬28) plasmid mixture resulted in fusion of the
entire cell monolayer (8 ⫻ 10 6 cells) within 48–72 h after
transfection (data not shown).
Transfections with p9–1513 or p9–1528 specifying gB
truncations of 64 and 49 amino acids, respectively, both
of which disrupt the predicted ␣-helical region H17a,
caused substantially less cell fusion (approximately 50%
reduction) than that of the wild-type gB gene (Figs. 2D
and 2E; Table 1). Previously, we showed that gB specified
by p9–1513 and p9–1528 was not as efficiently processed
through the Golgi as the gB specified by p9–2080 (wildtype) or p9–1511 (Baghian et al., 1993). Therefore, the
inability of these two mutant forms of gB to cause cell
fusion may be due to their altered processing and transport to cell surfaces.
The role of ␣-helical domain H17b in cell fusion
The 1511 gB truncation interrupted the predicted ␣-helical domain H17b, allowing only the first half of this
domain to be expressed (Fig. 1) (Baghian et al., 1993;
Pellett et al., 1985). To further assess the role of this
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FIG. 1. Schematic diagram of the carboxyl terminus of HSV-1 gB. The predicted secondary structure of the gB carboxyl-terminal 109 amino acids
is shown as described previously (Baghian et al., 1993; Pellett et al., 1985). The location of the gB truncations and mutations specified by plasmids
p9–1513, p9–1528, p9–1511, pCMV-gB(⌬28), pCMV-gB(⌬36), pCMV-gB(A874P), pCMV-gB(⌬16), and pCMV-gB(syn3) are shown. The ⌬ followed by a
number indicates the number of amino acids deleted from the carboxyl terminus of gB. The location of the two predicted ␣-helices, H17a and H17b,
are shown and marked by dashed lines.

domain in the transient fusion assay, additional mutated
gB genes were constructed and tested for their ability to
cause cell fusion. Plasmid pCMV-gB(⌬36) specifies a gB
truncated immediately before the H17b domain, while
plasmid pCMV-gB(⌬16) specifies gB truncated after the
H17b domain (Fig. 1). The gB(⌬16) truncation produced

fusion similar to wild-type gB (Figs. 4A and 4C). In contrast, gB(⌬36) caused similar levels of cell fusion to
gB(⌬28) (Figs. 4D and 4E). To evaluate the role of the
predicted ␣-helical structure of the H17b domain in cell
fusion, a single amino replacement was engineered into
the H17b domain by replacing alanine 874 with proline,

FIG. 2. Truncation of the carboxyl-terminal 28 amino acid of gB causes extensive fusion of transfected Cos cells. Cells were transfected with
plasmids expressing gD, gH/gL, and plasmids pCMV-gB (A), p9–2080 (B), p9–1537 (C), p9–1513 (D), p9–1528 (E), and p9–1511 (F). Transfected cells
were visualized by IFA at 36 h after transfection (65⫻ magnification).

gB AND HEPARIN INHIBITION OF CELL FUSION

21

FIG. 3. Quantitation of the effect of gB truncation on fusion of transfected Cos cells. Nuclei in 100 IFA-positive cells per assay were counted by two
observers and the average values and standard deviation were calculated.

causing disruption of the predicted ␣-helical structure
(Fig. 1). Expression of gB(A874P) produced cell fusion
similar to gB(⌬28) and gB(⌬36) (Figs. 4D–4F). For comparative purposes, we tested the ability of gB specified
by syncytial mutant HFEM(tsB5), which contains a missense syncytial mutation within the H17a ␣-helix, to
cause cell fusion. Transient expression of the gB(syn3)
gene did not increase cell fusion relative to the wild-type
gB, in agreement with results obtained with other HSV-1
gB syncytial mutations (Turner et al., 1998) (Figs. 4A and
4B). Polykaryocyte formation was quantified by counting
propidium iodide stained nuclei as explained earlier.
Results are summarized in Table 2.
The effect of heparin on gB-mediated cell fusion
Heparin is a potent inhibitor of virus penetration as
well as gB-mediated (syn3) virus-induced cell fusion

(Gruenheid et al., 1993; Herold et al., 1991, 1994; Shieh
et al., 1992; WuDunn and Spear, 1989). Transfected cell
monolayers were incubated either in the presence or
absence of heparin (10 mg/ml). Cell fusion was visualized through fluorescence microscopy and the levels
of observed cell fusion were quantified (Figs. 5 and 6).
Incubation of transfected cell monolayers with heparin
inhibited both wild-type gB and gB(syn3)-mediated cell
fusion (⬃85% inhibition) (Figs. 4, 5A, and 5B; Table 3)
as previously reported for tsB5 virus-induced cell fusion (Seck et al., 1994). In contrast, fusion of cells
expressing gB(⌬28) or gB(⌬36) was largely resistant to
heparin inhibition (Figs. 4, 5D, and 5E). Cell fusion
caused by gB(A874P) was inhibited by approximately
40% in heparin treated vs. untreated controls (Figs. 4
and 5F; Table 3). Heparin inhibited fusion caused by
gB(⌬16) by approximately 58% (Figs. 4 and 5C; Table 3).

TABLE 1
Truncation of the Carboxyl Terminal 28 Amino Acid of gB Causes Extensive Fusion of Transfected Cos Cells
Plasmids transfected
(all include gD, gHgL)
Total nuclei counted
Average nuclei
Standard deviation
Standard error
Median
Smallest no. of nuclei
Largest no. of nuclei
% change from gB

gB
1838
9.19
6.98
0.49
8
1
51
—

2080

1537

1528

1513

1511

1561
7.81
6.58
0.47
6
1
52

444
2.22
1.92
0.14
2
1
17

888
4.44
4.32
0.31
3
1
34

762
3.81
2.58
0.18
3
1
15

4460
22.30
20.21
1.43
16
1
129

⫺15.1%

⫺75.8%

⫺51.7%

⫺58.5%

142.7%
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FIG. 4. gB-H17b-targeted mutations enhance fusion of transfected Cos cells. Cells transfected with plasmids expressing gD, gH/gL, and gB (A),
gB(syn3) (B), gB(⌬16) (C), gB(⌬28) (D), gB (⌬36) (E), and gB (A874P) (F). Transfected cells were visualized by IFA at 36 h after transfection at 65⫻
magnification.

The effect of heparin on virus-induced cell fusion
Heparin was unable to fully inhibit cell fusion mediated
by truncated or mutated gB in the transient fusion assay.
Therefore, we assayed the effect of heparin on virus-

induced cell fusion caused by syncytial mutant viruses.
Syncytial viruses mp(MP), HFEM(tsB5), and amb1511
were engineered to constitutively express EGFP as described previously for the construction of the KOS/EGFP

TABLE 2
gB-H17b-Targeted Mutations Enhance Fusion of Transfected Cos Cells
Plasmids transfected
(all include gD, gHgL)
Total nuclei counted
Average nuclei
Standard deviation
Standard error
Median
Smallest no. of nuclei
Largest no. of nuclei
% Increase over wt gB

gB
2035
10.18
6.93
0.49
9
1
41
—

gB
(syn3)

gB
(⌬16)

gB
(⌬28)

gB
(⌬36)

gB
(A874P)

2340
11.7
8.61
0.61
11
1
44

2232
11.16
7.81
0.55
10
1
47

4146
20.73
15.62
1.1
17
1
92

4332
21.66
17.36
1.23
18
1
99

4000
20
14.33
1.01
18
1
80

14.9%

9.6%

103.6%

112.8%

96.5%
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TABLE 3
gB-H17b-Targeted Mutations Confer Resistance to Heparin Inhibition of Cell Fusion
Plasmids transfected
(all include gD, gHgL)
Total nuclei counted
Average nuclei
Standard deviation
Standard error
Median
Smallest no. of nuclei
Largest no. of nuclei
% Inhibition by heparin

gB

gB
(syn3)

gB
(⌬16)

gB
(⌬28)

gB
(⌬36)

gB
(A874P)

471
2.36
1.93
0.13
2
1
10

486
2.43
2.14
0.15
2
1
14

1059
5.3
5.07
1.1
3
1
26

3414
17.07
10.95
0.77
16
1
55

3397
16.99
14.04
0.99
13
1
91

2543
12.72
9.31
0.66
11
1
50

85.2%

86.6%

57.7%

18.6%

22.6%

38.3%

virus (Foster et al., 1999). Expression of EGFP from this
locus results in distinct nuclear and diffuse cytoplasmic
fluorescence, facilitating visualization of polykaryocytes
(Fig. 7). As previously reported (Seck et al., 1994), tsB5-

induced cell fusion was inhibited by heparin (Figs. 7C
and 7D). In contrast, fusion caused by mp(MP), which
contains the syn1 mutation in glycoprotein K (gK), was
not inhibited by heparin (Figs. 7G and 7H). Similar to the

FIG. 5. gB-H17b-targeted mutations confer resistance to heparin inhibition of cell fusion. Cells transfected with plasmids expressing gD, gH/gL, and
gB (A), gB(syn3) (B), gB(⌬16) (C), gB(⌬28) (D), gB (⌬36) (E), and gB (A874P) (F). Cells were incubated in the presence of heparin. Transfected cells were
visualized by IFA at 36 h after transfection at 65⫻ magnification.

24

FOSTER, MELANCON, AND KOUSOULAS

FIG. 6. Quantitative comparison of fusion of transfected cells in the presence and absence of heparin. Cell fusion represented in Fig. 4 (without
heparin) and Fig. 5 (with heparin) was quantitated as described in the legend of Fig. 3.

results obtained in the transient fusion assay, cell fusion
caused by mutant virus-amb1511/EGFP was resistant to
heparin inhibition (Figs. 7E and 7F).
DISCUSSION
Studies on the role of individual viral glycoproteins in
virus entry as well as virus-induced cell fusion are hampered by the fact that multiple glycoproteins and proteins
are involved in both processes. In this regard, the established model system for virus-associated membrane fusion phenomena via transient co-expression of gB, gD,
and gH/gL represents a reasonable model system to
investigate individual glycoprotein functions. However, it
is important to compare virus-induced cell fusion and
virus-free fusion systems to ensure that functional aspects of glycoproteins expressed in the transfection fusion system represent glycoprotein functions manifested
in the context of the viral genome. Our investigations
produced the following conclusions. First, we show that
the predicted ␣-helical domain H17b within the carboxyl
terminus of gB is involved in both virus-induced and
virus-free fusion systems. Second, heparin is a specific
inhibitor of gB-mediated fusion in both systems. Third,
resistance to heparin inhibition of gB-mediated cell fusion is associated with the predicted ␣-helical structure
H17b. Thus, gB-mediated fusion is functionally similar for
both fusion assays.
Previously, we showed that truncating gB by 28 amino
acids produced wild-type levels of mature gB and
caused extensive virus-induced cell fusion (Baghian et
al., 1993), while a truncation of 41 amino acids did not
affect virus replication and failed to cause cell fusion
(Huff et al., 1988). We proposed that the ␣-helical domain

H17b, which was interrupted by the 28-amino-acid truncation, must be involved in virus-induced cell fusion
(Baghian et al., 1993). Co-expression of the 28-aminoacid truncated gB specified by plasmid p9–1511 with gD,
and gH/gL caused extensive cell fusion as evidenced by
the formation of large-size polykaryocytes. The extent of
the fusion occurring after cotransfection of glycoprotein
genes containing the truncated gB was similar to virusinduced cell fusion caused by mutant viruses expressing
the gB (syn3) or gB(⌬28). Ultimately, transfection of Cos
cells led to fusion of the entire cell monolayer of up to
5 ⫻ 10 6 cells into a single syncytium within 48–72 h.
Clearly, the 28-amino-acid gB deletion functioned similarly in both the virus-induced cell fusion and virus-free
transfection fusion assay. Three conclusions can be
made based on these results. First, the ability of truncated gB to cause extensive cell fusion in the transfection fusion assay provides further evidence that certain
gB functions can be manifested in the absence of productive viral replication. Second, the truncated gB’s ability to extensively fuse membranes requires only the presence of co-expressed gD and gH/gL glycoproteins. Third,
the domains of gB that are responsible for this extensive
cell fusion phenotype, in both virus-induced and virusfree transfection systems, are located in the carboxyl
terminus of gB.
In agreement with our previous results, which implicated the H17b ␣-helical domain in virus-induced cell
fusion, we found that deletion of the entire H17b domain
or substitution of a single proline within the H17b helical
domain caused extensive cell fusion as evidenced by the
formation of large-size polykaryocytes. The ability of the
two gB truncations and the single proline residue sub-
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FIG. 7. Cell fusion caused by viruses specifying H17b-mutated gB is resistant to heparin inhibition. Vero cells were infected at an m.o.i. of 0.1 with
KOS/EGFP (A, B), tsb5/EGFP (C, D), amb1511/EGFP (E, F), and MP/EGFP (G, H) in the presence (B, D, F, H) or absence (A, C, E, G) of heparin. Infected
cells were visualized by fluorescence microscopy (65⫻ magnification).

stitution to cause extensive cell fusion indicates that the
predicted ␣-helical structure of H17b serves as a major
determinant for membrane fusion. All gB mutants, which
disrupted the predicted ␣-helical domain H17b either by
truncation or the proline substitution did not affect gB
synthesis or transport to cell surfaces as evidenced by
immunofluorescence against transfected cells fixed with
4% paraformaldehyde (not shown). Therefore, the ability
of these mutant gB forms to cause cell fusion is largely
due to their specific gB mutations. H17b is located immediately adjacent to the predicted 31-amino-acid-long
␣-helix, H17a, within which multiple syncytial mutations
have been mapped (Bzik et al., 1984a; Gage et al., 1993).

However, syncytial mutations within H17a and H17b can
be functionally differentiated with respect to their ability
to cause membrane fusion in the transfection fusion
system. The syn3 mutation within H17a failed to enhance
fusion in the transfection fusion assay. In contrast, both
the 36- and 28-amino-acid truncations as well as the
proline substitution affecting H17b readily caused extensive cell fusion. The most plausible explanation for these
results is that H17b functions as an independent fusion
domain regulator. Partial or full inactivation of this domain confers the ability on gB to cause extensive cell
fusion. Furthermore, fusion associated with this domain
requires the presence of only gD and gH/gL. In contrast,
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the H17a domain must require additional viral proteins
expressed during viral infection. Truncations and mutations in the gH carboxyl terminus have been shown to
inhibit cell fusion implying that the carboxyl terminus of
gH is also involved in membrane fusion (Browne et al.,
1996; Wilson et al., 1994). An alternative explanation of
the role of the H17b domain in cell fusion is that the
carboxyl termini of gB and gH functionally interact and
this interaction affects the fusogenic abilities of both gB
and gH. It is worth noting that there is a discrepancy
between trasfection fusion results obtained with HSV-1
and HSV-2 glycoproteins, inasmuch as a syn mutation
within HSV-2 gB was reported to enhance fusion in the
transfection fusion system (Muggeridge, 2000). HSV-2
enters faster into cells than HSV-1 implying the presence
of an enhanced mechanism for virus-to-cell fusion (DeLuca, 1981, Kousoulas, unpublished observations).
Therefore, the different dynamics of HSV-1 and HSV-2
glycoprotein-mediated membrane fusion phenomena
may account for the observed differences in fusion
caused by syncytial mutations within HSV-1 and HSV-2
gB.
Heparin is a specific inhibitor of gB-mediated virusinduced cell fusion (Seck et al., 1994). In agreement with
previous reports, we confirmed that heparin specifically
inhibited fusion caused by syncytial mutant HFEM (tsB5),
while it did not inhibit fusion caused by mutants with
syncytial mutations in gK. Heparin is known to predominantly bind to gC and secondarily to gB (Herold et al.,
1991, 1994; Laquerre et al., 1998; Spear et al., 1992). The
binding sites of other proteins exhibiting heparin-binding
activity have been mapped to dense regions of positively
charged residues containing variable lengths of arginine-rich and/or lysine-rich regions (Cardin et al., 1991;
Marino et al., 1999; Sendak and Bensadoun, 1998;
Sendak et al., 2000; Wong et al., 1995). The primary
sequence of gB contains a heparin binding site at amino
acids 68–76 (KPKKNKKPK) in the amino terminus of gB.
Deletion of this amino acid domain results in substantial
reduction in heparin binding of gB (Laquerre et al., 1998).
There are additional potential heparin binding sites
within gB at amino acid locations 158, 318, 494, 862, and
882 containing the consensus binding motif R/K-X-R/K.
The simplest explanation for the inhibitory effect of heparin on gB-mediated cell fusion is that heparin physically
blocks cell fusion. Heparin inhibited fusion in the transfection fusion system when full-copy gB, gD, and gH/gL
were co-expressed or when transfections contained the
gB(syn3)gene. However, heparin was unable to substantially inhibit fusion caused by truncations of gB that
delete all or part of the H17b ␣-helix. Heparin did partially
inhibit fusion caused by the single Ala to Pro substitution,
which inactivates the predicted ␣-helical structure of the
H17b domain. These differences between the truncated
gB and the proline substituted gB could be due to the
more severe nature of the truncations vs. the single
amino acid replacement in that certain amino acids up-

stream or downstream of the proline substitution may
confer partial susceptibility to heparin inhibition of membrane fusion. We offer the following hypotheses to explain the effect of heparin on gB-mediated cell fusion.
First, truncation of gB may affect the conformation of the
gB amino terminus resulting in the partial loss of heparin
binding. Second, gB truncations may cause changes in
the interaction of gB with cellular receptors, which render gB-mediated fusion resistant to heparin. In support of
the latter hypothesis, it was shown that bovine herpesvirus gB interacted with two types of receptors on Madin
Darby bovine kidney cells (MDBK), a heparan sulfate
proteoglycan, and an unknown high-affinity receptor, respectively. Truncated gB retained the ability to bind heparin, but not the ability to block the interaction of gB with
a high-affinity binding receptor on MDBK cells (Li et al.,
1996). Furthermore, deletion of the carboxyl terminus of
gB resulted in the loss of one monoclonal antibody
epitope located in the amino-terminal of gB, implying that
the truncated gB had assumed an altered conformation,
which was responsible for the loss of the binding to the
high-affinity receptor (Li et al., 1996). Additional evidence
that perturbations of the carboxyl terminus of gB may
affect the conformation of the gB extracellular portion
was provided by an Ala to Val change at position 851
within the syncytial region II of HSV-1 gB, which caused
delayed viral entry kinetics (Gage et al., 1993).
Substantial differences between the virus-induced and
transfection-induced fusion systems exist with respect to
the role of heparan sulfate moieties on cell surfaces.
Heparan sulfate enhanced virus-induced cell fusion, inasmuch as viruses with syncytial mutations failed to
readily fuse heparan sulfate-deficient cells. In contrast,
fusion caused by transient transfection of viral glycoproteins did not require the presence of heparan sulfate,
although it did require the presence of cell surface entry
receptors specific for gD (Pertel et al., 2001; Shieh and
Spear, 1994). Therefore, the ability of heparin to inhibit
both virus-induced cell fusion and virus-free fusion in the
transfection fusion assay must reflect direct inhibition of
gB-associated functions and not heparin-competitive inhibition of gB binding to heparan sulfate proteoglycans
on apposed cell surfaces. Such interactions, presumably,
would strengthen interactions between plasma membranes and facilitate membrane fusion.
Heparin is known to bind to a variety of important
proteins on cell surfaces and modulate the functions of
these proteins predominantly through signal transduction effects to intracellular targets. However, heparin can
also internalize into cells via specific or nonspecific receptors (Barzu et al., 1996; Heinzelmann et al., 1999;
Letourneur et al., 1995a,b; Watanabe et al., 1995). Therefore, it is possible that endocytosed heparin may directly
bind to the carboxyl terminus of gB at the predicted sites
located at amino acids 862 and 882. In this scenario,
resistance to heparin inhibition of cell fusion by truncated gB may be due to the lack of heparin binding sites,

gB AND HEPARIN INHIBITION OF CELL FUSION

particularly the site at amino acid 882, which is deleted
in both gB truncations. The reduced ability of heparin to
inhibit cell fusion caused by gB(A874P) and gB(⌬16) may
be the result of local conformational changes, which
prevent binding of heparin to upstream binding sites.
Additional experiments are needed to ascertain whether
heparin readily enters into gB-transfected cells and
whether the carboxyl terminus of gB is able to bind
heparin.
A carboxyl-terminal truncation of the PRV gB enhanced
both virus-induced and virus-free cell fusion (Klupp et al.,
2000; Nixdorf et al., 2000). However, in the virus-free
transfection assay, cell fusion can occur in the absence
of gD. Furthermore, a hybrid gD/gH protein composed of
the extracellular portion of gD fused in-frame to a portion
of gH, which contains the carboxyl terminus of gH including its membrane spanning region, functionally substituted the gH/gL heterodimer (Klupp and Mettenleiter,
1999; Klupp et al., 2000). We constructed and tested a
similar HSV-1 gD/gH fusion protein and found that it
failed to substitute for the presence of gD or gH/gL in the
virus-free fusion system (not shown). Thus, it is clear that
there are similarities between PRV and HSV-1 with respect to the role of the gB carboxyl terminus in cell
fusion, but also substantial differences with respect to
the functions of gD and gH/gL. In this regard, the apparent disparity between the two fusion systems may reflect
fundamental differences in the functions of these proteins as well as differences in their interactions with
cellular receptors (Nixdorf et al., 1999).
MATERIALS AND METHODS
Cells and viruses
Vero and COS7 cells were obtained from ATCC (Rockville, MD) and grown in Dulbecco’s modified Eagle’s
Medium (DMEM) supplemented with 10% fetal calf serum (FCS). KOS/EGFP specifies the enhanced green fluorescence protein (EGFP) from a CMV-EGFP gene cassette inserted within the intergenic region between the
UL53 and UL54 open reading frames (ORFs) (Foster et
al., 1999). To facilitate visualization of syncytia formation,
recombinant viruses amb1511/EGFP, MP/EGFP, and
tsB5/EGFP were constructed by insertion of a CMVEGFP gene cassette as described in detail previously for
the KOS/EGFP virus (Foster et al., 1999). All viruses were
propagated on Vero cells.
Construction of expression plasmids
Plasmid p9–2080 specifies a wild-type (wt) copy of gB;
whereas, plasmids p9–1511, p9–1513, p9–1528, and p9–
1537 specify carboxyl-terminally truncated gB driven by
the Adenovirus Major Late Promoter (Ad MLP) and were
as described previously (Baghian et al., 1993). The entire
open reading frames (ORFs) for gB and gD were amplified by PCR with specific primers that removed the 3⬘
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stop codon such that the genes were inserted in frame
with a V5 epitope tag when ligated to pcDNA3.1 TA TOPO
to generate plasmids pCMV-gB and pCMV-gD. Truncations in gB were generated by PCR. Plasmids gB(⌬36),
gB(⌬28), and gB(⌬16) express C-terminally truncated derivates of gB of 36, 28, and 16 amino acids (aa), respectively. A gB gene specifying a single codon change from
alanine to proline at amino acid 874 was produced by
splice-overlap extension (SOE) PCR utilizing synthetic
oligonucleotides containing the point mutation. The PCRderived gB(A874P) was ligated into pcDNA3.1 TA TOPO to
generate plasmid pCMV-gB(A874P). All plasmid inserts
were sequenced by Sanger dideoxy-chain termination
methodology using an automated DNA sequencer (PE
Biosystems, 377 Sequencer). Plasmid pcDNA3 gHgL
was kindly provided by A. Minson.
Cell fusion assay
In vitro cell fusion assays were performed essentially
as described previously (Klupp et al., 2000; Muggeridge,
2000; Turner et al., 1998). Briefly, the day prior to transfection, 35-mm 6-well plates were seeded with 8 ⫻ 10 4
COS7 cells. A total of 6 g of plasmid DNA encoding the
indicated glycoproteins was transfected with Superfect
(Qiagen, Valencia CA) according to the manufacturer’s
directions. Three hours post-transfection, media was aspirated and cells were overlaid with DMEM 5% FCS.
Where indicated, heparin (10 mg/ml) was included in the
overlay media. Twenty-four hours post-transfection, cells
were overlaid with 4 ⫻ 10 5 freshly trypsinized COS7 cells
per well with or without the inclusion of heparin. Cells
were subsequently incubated at 37°C for an additional
12 h before levels of fusion were determined.
Immunofluorescence assay and quantitation of fusion
Cells were fixed with 100% methanol for 10 min,
washed twice with TBS, and incubated at room temperature for 1 h with the primary antibody anti-V5 (Invitrogen,
Carlsbad, CA) diluted 1:200 in TBS-10% goat serum. Cells
were then washed three times with TBS and incubated
for 1 h at room temperature with FITC-conjugated goat
anti-mouse IgG (Sigma, St. Louis, MO) diluted 1:100 in
TBS-10% goat serum. After incubation, excess antibody
was removed by washing three times with TBS. Propidium iodide nuclear counterstain (Molecular Probes,
Eugene, OR) was applied to facilitate quantitation of
fusion. Fusion was examined on a Nikon Diaphot inverted fluorescent microscope. The number of nuclei in
100 transfected cells or polykaryocytes per well was
determined by two independent observers. Transfected
cells were defined as those cells that were IFA-positive.
Average values and standard deviations were then calculated from the combined data obtained by the two
observers. Percent change in levels of fusion over wildtype (wt) gB was calculated by the formula [(average
nuclei mutated gB) ⫺ (average nuclei wt gB)]/(average
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nuclei wt gB) ⫻ 100%. Percent inhibition of fusion by
heparin was defined as {[(average nuclei of untreated
assay) ⫺ 1] ⫺ [(average nuclei of heparin treated assay) ⫺ 1]}/[(average nuclei of untreated assay) ⫺ 1] ⫻
100%.
Heparin inhibition of viral polykaryocyte formation
Subconfluent Vero cells were infected at an m.o.i. of
0.1 for 1 h and subsequently overlaid with DMEM-2%
FCS, 1% methylcellulose either lacking or containing
heparin (10mg/ml). The amount of heparin used in the
virus-free fusion inhibition experiments was chosen on
the basis of being the amount required to inhibit virusinduced cell fusion. Lower amounts of heparin (1 mg/ml
instead of 10 mg/ml), effectively inhibited virus-free fusion caused by wild-type gB. Viral plaques were visualized by phase-contrast and fluorescent microscopy at
24 h post-infection.
ACKNOWLEDGMENTS
We thank A. Minson for the pcDNA3 gHgL plasmid and for helpful
technical advice. This work was supported by a grant from the National
Institute of Allergy and Infectious Diseases (AI43000) (to K.G.K.).

REFERENCES
Addison, C., Rixon, F. J., Palfreyman, J. W., O’Hara, M., and Preston, V. G.
(1984). Characterisation of a herpes simplex virus type 1 mutant
which has a temperature-sensitive defect in penetration of cells and
assembly of capsids. Virology 138, 246–259.
Baghian, A., Huang, L., Newman, S., Jayachandra, S., and Kousoulas,
K. G. (1993). Truncation of the carboxy-terminal 28 amino acids of
glycoprotein B specified by herpes simplex virus type 1 mutant
amb1511–7 causes extensive cell fusion. J. Virol. 67, 2396–2401.
Baines, J. D., Ward, P. L., Campadelli-Fiume, G., and Roizman, B. (1991).
The UL20 gene of herpes simplex virus 1 encodes a function necessary for viral egress. J. Virol. 65, 6414–6424.
Barzu, T., Pascal, M., Maman, M., Roque, C., Lafont, F., and Rousselet,
A. (1996). Entry and distribution of fluorescent antiproliferative heparin derivatives into rat vascular smooth muscle cells: Comparison
between heparin-sensitive and heparin-resistant cultures. J. Cell.
Physiol. 167, 8–21.
Bond, V. C., and Person, S. (1984). Fine structure physical map locations
of alterations that affect cell fusion in herpes simplex virus type 1.
Virology 132, 368–376.
Browne, H. M., Bruun, B. C., and Minson, A. C. (1996). Characterization
of herpes simplex virus type 1 recombinants with mutations in the
cytoplasmic tail of glycoprotein H. J. Gen. Virol. 77, 2569–2573.
Bzik, D. J., Fox, B. A., DeLuca, N. A., and Person, S. (1984a). Nucleotide
sequence of a region of the herpes simplex virus type 1 gB glycoprotein gene: Mutations affecting rate of virus entry and cell fusion.
Virology 137, 185–190.
Bzik, D. J., Fox, B. A., DeLuca, N. A., and Person, S. (1984b). Nucleotide
sequence specifying the glycoprotein gene, gB, of herpes simplex
virus type 1. Virology 133, 301–314.
Cai, W. H., Gu, B., and Person, S. (1988). Role of glycoprotein B of herpes
simplex virus type 1 in viral entry and cell fusion. J. Virol. 62, 2596–
2604.
Cai, W. Z., Person, S., DebRoy, C., and Gu, B. H. (1988). Functional
regions and structural features of the gB glycoprotein of herpes
simplex virus type 1. An analysis of linker insertion mutants. J. Mol.
Biol. 201, 575–588.
Cardin, A. D., Demeter, D. A., Weintraub, H. J., and Jackson, R. L. (1991).

Molecular design and modeling of protein-heparin interactions.
Methods Enzymol. 203, 556–583.
Cocchi, F., Menotti, L., Mirandola, P., Lopez, M., and Campadelli-Fiume,
G. (1998). The ectodomain of a novel member of the immunoglobulin
subfamily related to the poliovirus receptor has the attributes of a
bona fide receptor for herpes simplex virus types 1 and 2 in human
cells. J. Virol. 72, 9992–10002.
Davis-Poynter, N., Bell, S., Minson, T., and Browne, H. (1994). Analysis
of the contributions of herpes simplex virus type 1 membrane proteins to the induction of cell–cell fusion. J. Virol. 68, 7586–7590.
Debroy, C., Pederson, N., and Person, S. (1985). Nucleotide sequence of
a herpes simplex virus type 1 gene that causes cell fusion. Virology
145, 36–48.
DeLuca, N., Bzik, D. J., Bond, V. C., Person, S., and Snipes, W. (1982).
Nucleotide sequences of herpes simplex virus type 1 (HSV-1) affecting virus entry, cell fusion, and production of glycoprotein gb (VP7).
Virology 122, 411–423.
Dolter, K. E., Ramaswamy, R., and Holland, T. C. (1994). Syncytial
mutations in the herpes simplex virus type 1 gK (UL53) gene occur in
two distinct domains. J. Virol. 68, 8277–8281.
Engel, J. P., Boyer, E. P., and Goodman, J. L. (1993). Two novel single
amino acid syncytial mutations in the carboxy terminus of glycoprotein B of herpes simplex virus type 1 confer a unique pathogenic
phenotype. Virology 192, 112–120.
Forrester, A., Farrell, H., Wilkinson, G., Kaye, J., Davis-Poynter, N., and
Minson, T. (1992). Construction and properties of a mutant of herpes
simplex virus type 1 with glycoprotein H coding sequences deleted.
J. Virol. 66, 341–348.
Foster, T. P., Chouljenko, V. N., and Kousoulas, K. G. (1999). Functional
characterization of the HveA homolog specified by African green
monkey kidney cells with a herpes simplex virus expressing the
green fluorescence protein. Virology 258, 365–374.
Gage, P. J., Levine, M., and Glorioso, J. C. (1993). Syncytium-inducing
mutations localize to two discrete regions within the cytoplasmic
domain of herpes simplex virus type 1 glycoprotein B. J. Virol. 67,
2191–2201.
Geraghty, R. J., Krummenacher, C., Cohen, G. H., Eisenberg, R. J., and
Spear, P. G. (1998). Entry of ␣-herpesviruses mediated by poliovirus
receptor-related protein 1 and poliovirus receptor. Science 280,
1618–1620.
Gruenheid, S., Gatzke, L., Meadows, H., and Tufaro, F. (1993). Herpes
simplex virus infection and propagation in a mouse L cell mutant
lacking heparan sulfate proteoglycans. J. Virol. 67, 93–100.
Haanes, E. J., Nelson, C. M., Soule, C. L., and Goodman, J. L. (1994). The
UL45 gene product is required for herpes simplex virus type 1
glycoprotein B-induced fusion. J. Virol. 68, 5825–5834.
Heinzelmann, M., Platz, A., Flodgaard, H., Polk, H. C., Jr., and Miller, F. N.
(1999). Endocytosis of heparin-binding protein (CAP37) is essential
for the enhancement of lipopolysaccharide-induced TNF-␣ production in human monocytes. J. Immunol. 162, 4240–4245.
Herold, B. C., Visalli, R. J., Susmarski, N., Brandt, C. R., and Spear, P. G.
(1994). Glycoprotein C-independent binding of herpes simplex virus
to cells requires cell surface heparan sulphate and glycoprotein B.
J. Gen. Virol. 75, 1211–1222.
Herold, B. C., WuDunn, D., Soltys, N., and Spear, P. G. (1991). Glycoprotein C of herpes simplex virus type 1 plays a principal role in the
adsorption of virus to cells and in infectivity. J. Virol. 65, 1090–1098.
Huff, V., Cai, W., Glorioso, J. C., and Levine, M. (1988). The carboxyterminal 41 amino acids of herpes simplex virus type 1 glycoprotein
B are not essential for production of infectious virus particles. J. Virol.
62, 4403–4406.
Hutchinson, L., Goldsmith, K., Snoddy, D., Ghosh, H., Graham, F. L., and
Johnson, D. C. (1992). Identification and characterization of a novel
herpes simplex virus glycoprotein, gK, involved in cell fusion. J. Virol.
66, 5603–5609.
Jacobson, J. G., Martin, S. L., and Coen, D. M. (1989). A conserved open
reading frame that overlaps the herpes simplex virus thymidine

gB AND HEPARIN INHIBITION OF CELL FUSION
kinase gene is important for viral growth in cell culture. J. Virol. 63,
1839–1843.
Klupp, B. G., and Mettenleiter, T. C. (1999). Glycoprotein gL-independent
infectivity of pseudorabies virus is mediated by a gD-gH fusion
protein. J. Virol. 73, 3014–3022.
Klupp, B. G., Nixdorf, R., and Mettenleiter, T. C. (2000). Pseudorabies
virus glycoprotein M inhibits membrane fusion. J. Virol. 74, 6760–
6768.
Laquerre, S., Argnani, R., Anderson, D. B., Zucchini, S., Manservigi, R.,
and Glorioso, J. C. (1998). Heparan sulfate proteoglycan binding by
herpes simplex virus type 1 glycoproteins B and C, which differ in
their contributions to virus attachment, penetration, and cell-to-cell
spread. J. Virol. 72, 6119–6130.
Letourneur, D., Caleb, B. L., and Castellot, J. J., Jr. (1995a). Heparin
binding, internalization, and metabolism in vascular smooth muscle
cells. I. Upregulation of heparin binding correlates with antiproliferative activity. J. Cell. Physiol. 165, 676–686.
Letourneur, D., Caleb, B. L., and Castellot, J. J., Jr. (1995b). Heparin
binding, internalization, and metabolism in vascular smooth muscle
cells. II. Degradation and secretion in sensitive and resistant cells.
J. Cell. Physiol. 165, 687–695.
Li, Y., van Drunen Littel-van den Hurk, S., Liang, X., and Babiuk, L. A.
(1996). The cytoplasmic domain of bovine herpesvirus 1 glycoprotein
B is important for maintaining conformation and the high-affinity
binding site of gB. Virology 222, 262–268.
Ligas, M. W., and Johnson, D. C. (1988). A herpes simplex virus mutant
in which glycoprotein D sequences are replaced by ␤-galactosidase
sequences binds to but is unable to penetrate into cells. J. Virol. 62,
1486–1494.
Manservigi, R., Spear, P. G., and Buchan, A. (1977). Cell fusion induced
by herpes simplex virus is promoted and suppressed by different
viral glycoproteins. Proc. Natl. Acad. Sci. USA 74, 3913–3917.
Marino, M., Friedlander, J. A., McCluskey, R. T., and Andrews, D. (1999).
Identification of a heparin-binding region of rat thyroglobulin involved
in megalin binding. J. Biol. Chem. 274, 30377–30386.
Mettenleiter, T. C. (2000). Aujeszky’s disease (pseudorabies) virus: The
virus and molecular pathogenesis—state of the art, June 1999. Vet.
Res. 31, 99–115.
Montgomery, R. I., Warner, M. S., Lum, B. J., and Spear, P. G. (1996).
Herpes simplex virus-1 entry into cells mediated by a novel member
of the TNF/NGF receptor family. Cell 87, 427–436.
Muggeridge, M. I. (2000). Characterization of cell-cell fusion mediated
by herpes simplex virus 2 glycoproteins gB, gD, gH and gL in
transfected cells. J. Gen. Virol. 81, 2017–2027.
Nixdorf, R., Klupp, B. G., Karger, A., and Mettenleiter, T. C. (2000). Effects
of truncation of the carboxy terminus of pseudorabies virus glycoprotein B on infectivity. J. Virol. 74, 7137–7145.
Nixdorf, R., Schmidt, J., Karger, A., and Mettenleiter, T. C. (1999). Infection of Chinese hamster ovary cells by pseudorabies virus. J. Virol.
73, 8019–8026.
Novotny, M. J., Parish, M. L., and Spear, P. G. (1996). Variability of herpes
simplex virus 1 gL and anti-gL antibodies that inhibit cell fusion but
not viral infectivity. Virology 221, 1–13.
Pellett, P. E., Kousoulas, K. G., Pereira, L., and Roizman, B. (1985).
Anatomy of the herpes simplex virus 1 strain F glycoprotein B gene:
Primary sequence and predicted protein structure of the wild type
and of monoclonal antibody-resistant mutants. J. Virol. 53, 243–253.
Pertel, P. E., Fridberg, A., Parish, M. L., and Spear, P. G. (2001). Cell
fusion induced by herpes simplex virus glycoproteins gB, gD, and
gH-gL requires a gD receptor but not necessarily heparan sulfate.
Virology 279, 313–324.
Pertel, P. E., and Spear, P. G. (1996). Modified entry and syncytium
formation by herpes simplex virus type 1 mutants selected for resistance to heparin inhibition. Virology 226, 22–33.
Pogue-Geile, K. L., and Spear, P. G. (1987). The single base pair
substitution responsible for the Syn phenotype of herpes simplex
virus type 1, strain MP. Virology 157, 67–74.
Roop, C., Hutchinson, L., and Johnson, D. C. (1993). A mutant herpes

29

simplex virus type 1 unable to express glycoprotein L cannot enter
cells, and its particles lack glycoprotein H. J. Virol. 67, 2285–2297.
Ruyechan, W. T., Morse, L. S., Knipe, D. M., and Roizman, B. (1979).
Molecular genetics of herpes simplex virus. II. Mapping of the major
viral glycoproteins and of the genetic loci specifying the social
behavior of infected cells. J. Virol. 29, 677–697.
Sanders, P. G., Wilkie, N. M., and Davison, A. J. (1982). Thymidine kinase
deletion mutants of herpes simplex virus type 1. J. Gen. Virol. 63,
277–295.
Seck, T., Lingen, M., Weise, K., and Falke, D. (1994). Evidence for a
multistep mechanism for cell-cell fusion by herpes simplex virus with
mutations in the syn 3 locus using heparin derivatives during fusion
from within. Arch. Virol. 136, 173–181.
Sendak, R. A., and Bensadoun, A. (1998). Identification of a heparinbinding domain in the distal carboxyl-terminal region of lipoprotein
lipase by site-directed mutagenesis. J. Lipid Res. 39, 1310–1315.
Sendak, R. A., Berryman, D. E., Gellman, G., Melford, K., and Bensadoun, A. (2000). Binding of hepatic lipase to heparin. Identification of
specific heparin-binding residues in two distinct positive charge
clusters. J. Lipid Res. 41, 260–268.
Shieh, M. T., and Spear, P. G. (1994). Herpesvirus-induced cell fusion
that is dependent on cell surface heparan sulfate or soluble heparin.
J. Virol. 68, 1224–1228.
Shieh, M. T., WuDunn, D., Montgomery, R. I., Esko, J. D., and Spear, P. G.
(1992). Cell surface receptors for herpes simplex virus are heparan
sulfate proteoglycans. J. Cell Biol. 116, 1273–1281.
Spear, P. G. (1993). Entry of ␣-herpesviruses into cells. Semin. Virol. 4,
167–180.
Spear, P. G., Shieh, M. T., Herold, B. C., WuDunn, D., and Koshy, T. I.
(1992). Heparan sulfate glycosaminoglycans as primary cell surface
receptors for herpes simplex virus. Adv. Exp. Med. Biol. 313, 341–353.
Terry-Allison, T., Montgomery, R. I., Whitbeck, J. C., Xu, R., Cohen, G. H.,
Eisenberg, R. J., and Spear, P. G. (1998). HveA (herpesvirus entry
mediator A), a coreceptor for herpes simplex virus entry, also participates in virus-induced cell fusion. J. Virol. 72, 5802–5810.
Turner, A., Bruun, B., Minson, T., and Browne, H. (1998). Glycoproteins
gB, gD, and gHgL of herpes simplex virus type 1 are necessary and
sufficient to mediate membrane fusion in a Cos cell transfection
system. J. Virol. 72, 873–875.
Visalli, R. J., and Brandt, C. R. (1991). The HSV-1 UL45 gene product is
not required for growth in Vero cells. Virology 185, 419–423.
Walev, I., Lingen, M., Lazzaro, M., Weise, K., and Falke, D. (1994).
Cyclosporin A resistance of herpes simplex virus-induced “fusion
from within” as a phenotypical marker of mutations in the Syn 3 locus
of the glycoprotein B gene. Virus Genes 8, 83–86.
Warner, M. S., Geraghty, R. J., Martinez, W. M., Montgomery, R. I.,
Whitbeck, J. C., Xu, R., Eisenberg, R. J., Cohen, G. H., and Spear, P. G.
(1998). A cell surface protein with herpesvirus entry activity (HveB)
confers susceptibility to infection by mutants of herpes simplex virus
type 1, herpes simplex virus type 2, and pseudorabies virus. Virology
246, 179–189.
Watanabe, J., Haba, M., and Yuasa, H. (1995). Uptake of fractionated
3H-heparin by isolated rat Kupffer cells. Pharm. Res. 12, 1092–1095.
Weise, K., Kaerner, H. C., Glorioso, J., and Schroder, C. H. (1987).
Replacement of glycoprotein B gene sequences in herpes simplex
virus type 1 strain ANG by corresponding sequences of the strain
KOS causes changes of plaque morphology and neuropathogenicity.
J. Gen. Virol. 68, 1909–1919.
Wilson, D. W., Davis-Poynter, N., and Minson, A. C. (1994). Mutations in
the cytoplasmic tail of herpes simplex virus glycoprotein H suppress
cell fusion by a syncytial strain. J. Virol. 68, 6985–6993.
Wong, P., Hampton, B., Szylobryt, E., Gallagher, A. M., Jaye, M., and
Burgess, W. H. (1995). Analysis of putative heparin-binding domains
of fibroblast growth factor-1. Using site-directed mutagenesis and
peptide analogues. J. Biol. Chem. 270, 25805–25811.
WuDunn, D., and Spear, P. G. (1989). Initial interaction of herpes simplex
virus with cells is binding to heparan sulfate. J. Virol. 63, 52–58.

